Atomoxetine in the Treatment of Binge Eating Disorder

NCT00327834 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Binge-eating Disorder

Interventions

DRUG: atomoxetine

Sponsor

Lindner Center of HOPE

Collaborators

[object Object]